Position in ELVN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$620,418
New position
Shares Held
15,827
first reported quarter
Ownership
0.026%
of shares outstanding
% of Portfolio
0.56%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Biotechnology
Healthcare · as of Mar 31, 2026Scientech Research LLC holds $15,557,509 across 57 Biotechnology names. ELVN ranks #8 (4.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | WVE |
Wave Life Sciences Ltd.
|
200,331 | $1,452,399 | |
| 2 | SRRK |
Scholar Rock Holding Corp
|
26,288 | $1,292,318 | |
| 3 | VRDN |
Viridian Therapeutics, Inc.DE
|
65,080 | $1,272,964 | |
| 4 | CTMX |
CytomX Therapeutics, Inc.
|
230,598 | $1,083,810 | |
| 5 | NKTR |
Nektar Therapeutics
|
11,032 | $793,752 | |
| 6 | SRPT |
Sarepta Therapeutics, Inc.
|
33,008 | $718,254 | |
| 7 | ALMS |
Alumis Inc.
|
29,405 | $647,792 | |
| 8 | ELVN |
Enliven Therapeutics, Inc.
This page
|
15,827 | $620,418 |
All Filings in ELVN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $620,418 | 15,827 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||